A Trial to Evaluate the Safety and Immunogenicity of Monovalent H5N1 Vaccine in Adults >=18 Yrs of Age

The purpose of this study is to determine whether GSK's avian flu vaccine GSK 1557484A is immunogenic and safe when given to adults aged >=18 years. This Protocol Posting has been updated following Amendments 1-3 of the Protocol, Dec 2009. The impacted sections are study design and outcome m...

Full description

Bibliographic Details
Main Author: GlaxoSmithKline
Format: Dataset
Language:unknown
Published: Vivli 2018
Subjects:
Conditions Influenza
Interventions A/turkey H5N1 vaccine
Interventions Influenza A H5N1 Virus Monovalent Vaccine, Adjuvanted A/Indonesia
Interventions Placebo
Avian flu
Online Access:https://dx.doi.org/10.25934/00002091
https://search.vivli.org/doiLanding/studies/00002091/isLanding
Description
Summary:The purpose of this study is to determine whether GSK's avian flu vaccine GSK 1557484A is immunogenic and safe when given to adults aged >=18 years. This Protocol Posting has been updated following Amendments 1-3 of the Protocol, Dec 2009. The impacted sections are study design and outcome measures.

Similar Items